>Tarceva test case in India

The outcomes of two pending challenges to the Indian patent for Roche's Tarceva erlotinib should shed some light on how Indian IP law will be applied to innovator drugs.

Last month, Roche filed an infringement lawsuit against Cipla Ltd.over the Indian company's generic version of Tarceva. Separately, Natco Pharma Ltd.is trying to obtain a compulsory license to export Tarceva to Nepal. ...